Brief: JHBP CY Received Investigational New Drug Approval For Gb492 By NMPA
20/05/2021 01:21
May 20 (Reuters) - JHBP CY Holdings Ltd 6998.HK :
* RECEIVED INVESTIGATIONAL NEW DRUG APPROVAL FOR GB492 BY
NATIONAL
MEDICAL PRODUCTS ADMINISTRATION
Source text for Eikon: ID:nHKS9w8bbg
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman